Skip to main content

Table 2 Overall survival multivariate analysis

From: CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

 

Cohort A

Cohort B

HR

CI 95%

P value

HR

CI 95%

P value

MMP-9 in CD68

1.26

0.20–10.35

0.81

  

0.2

MMP-9 in CD163

0.46

0.07–2.23

0.35

1.99

0.27–13.44

0.47

CD163

1.71

0.88–3.5

0.11

0.45

0.08–2.25

0.33

CD68

1.58

0.66–4.02

0.3

13.44

0.76–382.29

0.07

Age >50 years

6.24

2.13–20.21

0.0006

2.6

0.27–58.1

0.41

Size >2 cm

1.14

0.49–2.69

0.75

3.4

0.11–103

0.42

Grade

1.67

0.87–3.16

0.11

0.41

0.03–9.36

0.51

  1. Abbreviations: CI confidence interval, HR hazard ratio, MMP-9 matrix metalloproteinase 9
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us